Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients? - Université de Lorraine
Journal Articles Nephrology Dialysis Transplantation Year : 2021

Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?

Domains

Cardiology and cardiovascular system
Fichier principal
Vignette du fichier
Should renin angiotensin aldosterone system inhibition enablement be a therapeutic target in CKD patients .pdf (247.7 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Erwan BOZEC  : Connect in order to contact the contributor

https://hal.univ-lorraine.fr/hal-03274455

Submitted on : Wednesday, June 30, 2021-10:08:20 AM

Last modification on : Monday, September 25, 2023-12:30:08 PM

Long-term archiving on : Friday, October 1, 2021-6:16:05 PM

Download

Dates and versions

hal-03274455 , version 1 (30-06-2021)

Identifiers

Cite

Patrick Rossignol, Rajiv Agarwal. Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?. Nephrology Dialysis Transplantation, 2021, 36 (10), pp.1771-1772. ⟨10.1093/ndt/gfab061⟩. ⟨hal-03274455⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-LORRAINE DCAC-UL BMS-UL
27 View
112 Download

Altmetric

Share

More